These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 11593331

  • 1. Prostate-specific targeting using PSA promoter-based lentiviral vectors.
    Yu D, Chen D, Chiu C, Razmazma B, Chow YH, Pang S.
    Cancer Gene Ther; 2001 Sep; 8(9):628-35. PubMed ID: 11593331
    [Abstract] [Full Text] [Related]

  • 2. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
    Latham JP, Searle PF, Mautner V, James ND.
    Cancer Res; 2000 Jan 15; 60(2):334-41. PubMed ID: 10667585
    [Abstract] [Full Text] [Related]

  • 3. Prostate-specific expression of the diphtheria toxin A chain (DT-A): studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer.
    Li Y, McCadden J, Ferrer F, Kruszewski M, Carducci M, Simons J, Rodriguez R.
    Cancer Res; 2002 May 01; 62(9):2576-82. PubMed ID: 11980652
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Regression of prostate cancer xenografts by a lentiviral vector specifically expressing diphtheria toxin A.
    Zheng JY, Chen D, Chan J, Yu D, Ko E, Pang S.
    Cancer Gene Ther; 2003 Oct 01; 10(10):764-70. PubMed ID: 14502229
    [Abstract] [Full Text] [Related]

  • 6. Tightly-regulated suicide gene expression kills PSA-expressing prostate tumor cells.
    Peng W, Chen J, Huang YH, Sawicki JA.
    Gene Ther; 2005 Nov 01; 12(21):1573-80. PubMed ID: 16034457
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter.
    Petrigliano FA, Virk MS, Liu N, Sugiyama O, Yu D, Lieberman JR.
    Prostate; 2009 Sep 15; 69(13):1422-34. PubMed ID: 19489029
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Development of a new plasmid vector with PSA-promoter and enhancer expressing tissue-specificity in prostate carcinoma cell lines.
    Lee SE, Jin RJ, Lee SG, Yoon SJ, Park MS, Heo DS, Choi H.
    Anticancer Res; 2000 Sep 15; 20(1A):417-22. PubMed ID: 10769689
    [Abstract] [Full Text] [Related]

  • 11. Coexpression of the partial androgen receptor enhances the efficacy of prostate-specific antigen promoter-driven suicide gene therapy for prostate cancer cells at low testosterone concentrations.
    Suzuki S, Tadakuma T, Asano T, Hayakawa M.
    Cancer Res; 2001 Feb 15; 61(4):1276-9. PubMed ID: 11245419
    [Abstract] [Full Text] [Related]

  • 12. Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer.
    Gotoh A, Ko SC, Shirakawa T, Cheon J, Kao C, Miyamoto T, Gardner TA, Ho LJ, Cleutjens CB, Trapman J, Graham FL, Chung LW.
    J Urol; 1998 Jul 15; 160(1):220-9. PubMed ID: 9628654
    [Abstract] [Full Text] [Related]

  • 13. [Establishment of RNA interfering retrovirus vector targeting CXCR4 gene driven by human prostate-specific antigen promoter and its biological effects on prostate cancer cells].
    Du YF, Xing YF, Zeng FQ, Lu P, Liu XY, Xiao YJ.
    Zhonghua Zhong Liu Za Zhi; 2007 Jul 15; 29(7):489-94. PubMed ID: 18069626
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
    Lowe SL, Rubinchik S, Honda T, McDonnell TJ, Dong JY, Norris JS.
    Gene Ther; 2001 Sep 15; 8(18):1363-71. PubMed ID: 11571575
    [Abstract] [Full Text] [Related]

  • 16. A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression.
    Rubinchik S, Wang D, Yu H, Fan F, Luo M, Norris JS, Dong JY.
    Mol Ther; 2001 Nov 15; 4(5):416-26. PubMed ID: 11708878
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line.
    Karr JF, Kantor JA, Hand PH, Eggensperger DL, Schlom J.
    Cancer Res; 1995 Jun 01; 55(11):2455-62. PubMed ID: 7538903
    [Abstract] [Full Text] [Related]

  • 20. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL, Gardner TA, Miao L, Balian G, Chung LW.
    Cancer Gene Ther; 2004 Feb 01; 11(2):148-55. PubMed ID: 14695756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.